Primer estudio piloto para el tamizaje neonatal de linfopenias T y B en Colombia

Sebastián Gutiérrez-Hincapié , Carlos Muskus-López , Isaura Pilar Sánchez , José Luis Franco-Restrepo , Claudia M. Trujillo-Vargas, .

Palabras clave: tamización neonatal, linfopenia, linfocitos T, linfocitos B, inmunodeficiencia combinada grave

Resumen

Introducción. La detección temprana de linfopenias congénitas facilitaría su tratamiento oportuno y la prevención de complicaciones serias, y optimizaría los recursos del sistema de salud.
Objetivo. Realizar un estudio piloto para el tamizaje neonatal de linfopenias mediante la cuantificación de los círculos de escisión (TREC y KREC) de los receptores de los linfocitos T y B en muestras de sangre periférica de neonatos de Medellín, Colombia.
Materiales y métodos. Se recolectaron muestras de 1.092 neonatos y de seis pacientes con sospecha de linfopenia, mediante pinchazo del talón o del dedo gordo del pie. Se extrajo el ADN y se midieron los niveles de TREC y KREC por qPCR.
Resultados. En los seis pacientes con sospecha de linfopenia se encontraron niveles muy bajos o indetectables de TREC. Todos los neonatos tamizados presentaron niveles normales de TREC y KREC. Se observó concordancia entre los valores de TREC o de KREC en dos tipos diferentes de papel de filtro. Los niveles de TREC y KREC disminuyeron considerablemente después de 24 semanas de almacenamiento de las muestras de sangre en papel de filtro. Se encontró una asociación positiva entre los niveles de los TREC y el peso al nacer, y una correlación negativa entre los KREC y la edad gestacional. Los niveles de estos marcadores no se asociaron con el tipo de parto.
Conclusiones. Se presenta el primer estudio piloto para el tamizaje temprano de linfopenias congénitas en neonatos en Colombia. Se propone el uso de un límite de detección de 119 y 69 copias/μl de sangre de TREC y KREC, respectivamente, para futuros programas de detección neonatal de linfopenias en el país.

Descargas

Los datos de descargas todavía no están disponibles.
  • Sebastián Gutiérrez-Hincapié Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia https://orcid.org/0000-0002-1576-595X
  • Carlos Muskus-López Programa de Estudio y Control en Enfermedades Tropicales – PECET, Universidad de Antioquia, Medellín, Colombia https://orcid.org/0000-0003-4280-5627
  • Isaura Pilar Sánchez Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Grupo de Investigaciones Biomédicas UniRemington, Facultad de Ciencias de la Salud, Corporación Universitaria Remington, Medellín, Colombia https://orcid.org/0000-0002-1415-0785
  • José Luis Franco-Restrepo Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia https://orcid.org/0000-0001-5664-6415
  • Claudia M. Trujillo-Vargas Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia https://orcid.org/0000-0001-8546-2666

Referencias bibliográficas

Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: More common than generally thought. J Clin Immunol. 2013;33:1-7. https://doi.org/10.1007/s10875-012-9751-7

Quinn J, Modell V, Orange JS, Modell F. Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network. Allergy Asthma Clin Immunol. 2022;18:19. https://doi.org/10.1186/s13223-022-00662-6

Dorsey MJ, Wright NAM, Chaimowitz NS, Dávila-Saldaña BJ, Miller H, Keller MD, et al. Infections in infants with SCID: Isolation, infection screening, and prophylaxis in PIDTC centers. J Clin Immunol. 2021;41:38-50. https://doi.org/10.1007/s10875-020-00865-9

Barry JC, Crowley TB, Jyonouchi S, Heimall J, Zackai EH, Sullivan KE, et al. Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. J Clin Immunol. 2017;37:476-85. https://doi.org/10.1007/s10875-017-0403-9

Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42:1473-507. https://doi.org/10.1007/s10875-022-01289-3

Lev A, Somech R, Somekh I. Newborn screening for severe combined immunodeficiency and inborn errors of immunity. Curr Opin Pediatr. 2023;35:692-702. https://doi.org/10.1097/MOP.0000000000001291

Eissa H, Thakar MS, Shah AJ, Logan BR, Griffith LM, Dong H, et al. Post-transplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. J Allergy Clin Immunol. 2024;153:287-96. https://doi.org/10.1016/j.jaci.2023.09.027

Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet. 2000;355:1875-81. https://doi.org/10.1016/S0140-6736(00)02293-5

Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005;115:391-8. https://doi.org/10.1016/j.jaci.2004.10.012

Routes JM, Grossman WJ, Verbsky J, Laessig RH, Hoffman GL, Brokopp CD, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009;302:2465-70. https://doi.org/10.1001/jama.2009.1806

Dorsey MJ, Puck JM. Newborn screening for severe combined immunodeficiency in the United States: Lessons learned. Immunol Allergy Clin North Am. 2019;39:1-11. https://doi.org/10.1016/j.iac.2018.08.002

van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204:645-55. https://doi.org/10.1084/jem.20060964

Kanegae MPP, Barreiros LA, Sousa JL, Brito MAS, de Oliveira Junior EB, Soares LP, et al. Newborn screening for severe combined immunodeficiencies using TRECS and KRECS: Second pilot study in Brazil. Rev Paul Pedriatr. 2017;35:25-32. https://doi.org/10.1590/1984-0462/;2017;35;1;00013

Tagliaferri L, Kunz JB, Happich M, Esposito S, Bruckner T, Hübschmann D, et al. Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC). Clin Immunol. 2017;175:51-5. https://doi.org/10.1016/j.clim.2016.11.016

Giraldo GA, Suárez-Obando F, Mora L, Sánchez P, Prieto JC. Evaluation of TSH levels in the program of congenital hypothyroidism newborn screening in a pilot study of preterm newborns in Bogotá, Colombia. J Inborn Errors Metab Screen. 2015;3. https://doi.org/10.1177/2326409815597706

Sottini A, Serana F, Bertoli D, Chiarini M, Valotti M, Vaglio-Tessitore M, et al. Simultaneous quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) by real-time PCR. J Vis Exp. 2014;94:52184. https://doi.org/10.3791/52184

Baker MW, Grossman WJ, Laessig RH, Hoffman GL, Brokopp CD, Kurtycz DF, et al. Development of a routine newborn screening protocol for severe combined immunodeficiency. J Allergy Clin Immunol. 2009;124:522-7. https://doi.org/10.1016/j.jaci.2009.04.007

Kwan A, Hu D, Song M, Gomes H, Brown DR, Bourque T, et al. Successful newborn screening for SCID in the Navajo Nation. Clin Immunol. 2015;158:29-34. https://doi.org/10.1016/j.clim.2015.02.015

Esquerda M, Palau F, Lorenzo D, Cambra FJ, Bofarull M, Cusi V, et al. Ethical questions concerning newborn genetic screening. Clin Genet. 2021;99:93-8. https://doi.org/10.1111/cge.13828

Evans A, Bonhomme N, Goodman A, Terry SF. Newborn screening and health communications. Genet Test Mol Biomarkers. 2018;22:507-8. https://doi.org/10.1089/gtmb.2018.0234

van der Spek J, Groenwold RH, van der Burg M, van Montfrans JM. TREC based newborn screening for severe combined immunodeficiency disease: A systematic review. J Clin Immunol. 2015;35:416-30. https://doi.org/10.1007/s10875-015-0152-6

Kimizu T, Nozaki M, Okada Y, Sawada A, Morisaki M, Fujita H, et al. Multiplex real-time PCR-based newborn screening for severe primary immunodeficiency and spinal muscular atrophy in Osaka, Japan: Our results after 3 years. Genes (Basel). 2024;15:314. https://doi.org/10.3390/genes15030314

Taylor JL, Lee FK, Yazdanpanah GK, Staropoli JF, Liu M, Carulli JP, et al. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency. Clin Chem. 2015;61:412-9. https://doi.org/10.1373/clinchem.2014.231019

De Felipe B, Olbrich P, Goycochea-Valdivia W, Delgado-Pecellin C, Sánchez-Moreno P, Sánchez B, et al. Newborn screening for primary T- and B-cell immune deficiencies—A prospective study in Andalucía. Int J Neonatal Screen. 2017;3:27. https://doi.org/10.3390/ijns3040027

Rechavi E, Lev A, Simon AJ, Stauber T, Daas S, Saraf-Levy T, et al. First year of Israeli newborn screening for severe combined immunodeficiency – Clinical achievements and insights. Front Immunol. 2017;8:1448. https://doi.org/10.3389/fimmu.2017.01448

Zhao Q, Dai R, Li Y, Wang Y, Chen X, Shu Z, et al. Trends in TREC values according to age and gender in Chinese children and their clinical applications. Eur J Pediatr. 2022;181:529-38. https://doi.org/10.1007/s00431-021-04223-8

Ward CE, Baptist AP. Challenges of newborn severe combined immunodeficiency screening among premature infants. Pediatrics. 2013;131:e1298-302. https://doi.org/10.1542/peds.2012-1921

Audrain M, Thomas C, Mirallie S, Bourgeois N, Sebille V, Rabetrano H, et al. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single center study. Clin Immunol. 2014;150:137-9. https://doi.org/10.1016/j.clim.2013.11.012

Gaviglio A, Lasarev M, Sheller R, Singh S, Baker M. Newborn screening for severe combined immunodeficiency: Lessons learned from screening and follow-up of the preterm newborn population. Int J Neonatal Screen. 2023;9:68. https://doi.org/10.3390/ijns9040068

Wirbelauer J, Thomas W, Rieger L, Speer CP. Intrauterine growth retardation in preterm infants ≤ 32 weeks of gestation is associated with low white blood cell counts. Am J Perinatol. 2010;27:819-24. https://doi.org/10.1055/s-0030-1254547

Olearo E, Oberto M, Oggè G, Botta G, Pace C, Gaglioti P, et al. Thymic volume in healthy, small for gestational age and growth-restricted fetuses. Prenat Diagn. 2012;32:662-7. https://doi.org/10.1002/pd.3883

Schlinzig T, Johansson S, Stephansson O, Hammarström L, Zetterström RH, von Döbeln U, et al. Surge of immune cell formation at birth differs by mode of delivery and infant characteristics – A population-based cohort study. PloS ONE. 2017;12:e0184748. https://doi.org/10.1371/journal.pone.0184748

Neu J, Rushing J. Cesarean versus vaginal delivery: Long-term infant outcomes and the hygiene hypothesis. Clin Perinatol. 2011;38:321-31. https://doi.org/10.1016/j.clp.2011.03.008

Kristensen K, Henriksen L. Cesarean section and disease associated with immune function. J Allergy Clin Immunol. 2016;137:587-90. https://doi.org/10.1016/j.jaci.2015.07.040

Barreiros LA, Sousa JL, Geier C, Leiss-Piller A, Kanegae MPP, França TT, et al. SCID and other inborn errors of immunity with low TRECs – The Brazilian Experience. J Clin Immunol. 2022;42:1171-92. https://doi.org/10.1007/s10875-022-01275-9

Kumarasamy G, Khairiz K, Chang WL, Aye TT, Ali A. Paving the way in implementation of SCID newborn screening in developing nations: Feasibility study and strategies to move forward in Malaysia. Front Immunol. 2024;15:1400247. https://doi.org/10.3389/fimmu.2024

Huang J, Shankar A, Hurden I, Thomas R, Hill J, Seth D, et al. Increased mortality in infants with abnormal T-cell receptor excision circles. Pediatr Res. 2024;96:199-207. https://doi.org/10.1038/s41390-024-03121-7

Shih ST, Keller E, Wiley V, Wong M, Farrar MA, Chambers GM. Economic evaluation of newborn screening for severe combined immunodeficiency. Int J Neonatal Screen. 2022;8:44. https://doi.org/1010.3390/ijns8030044

Cómo citar
1.
Gutiérrez-Hincapié S, Muskus-López C, Sánchez IP, Franco-Restrepo JL, Trujillo-Vargas CM. Primer estudio piloto para el tamizaje neonatal de linfopenias T y B en Colombia. Biomed. [Internet]. 23 de diciembre de 2024 [citado 2 de abril de 2025];44(Sp. 2):94-106. Disponible en: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/7568
Publicado
2024-12-23
Sección
Artículos originales

Métricas

Estadísticas de artículo
Vistas de resúmenes
Vistas de PDF
Descargas de PDF
Vistas de HTML
Otras vistas
Crossref Cited-by logo
QR Code